LifeScience BioChemicals
Aptamer Group's Chief Technical Officer, Dr David Bunka, speaks to BioPharma APAC about the innovative Optimer-Fc reagent solution for immunohistochemistry...
March 29, 2023 | Influencers
Ronaflux® pigments: Metallic look without any metal content Zinc oxide UV filters: Launch of new, high-purity and sun protection solutions for ...
March 24, 2023 | News
Two top 10 pharma companies are seeking to trial Optimer-Fc for IHC Aptamer is currently working with one of the top three IHC companies to validate the...
March 21, 2023 | News
Cytrellis Biosystems, a pioneer in novel medical aesthetic solutions, celebrates the delivery of the 100th ellacor system with Micro-Coring Technology...
March 20, 2023 | News
Aquavit Holdings, the exclusive licensee of Huons Global's Botulinum Toxin in the USA and Canada, will officially unveil the Aquatox™ ...
March 18, 2023 | Regulatory
Scientists in Spain will now benefit from a locally-based team that will provide a single point of access to the Thermo Fisher Scientific portfolio of ion ...
March 17, 2023 | News
The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker®...
March 09, 2023 | News
Biosynth announces that its site in Lelystad, The Netherlands, successfully passed the recent GMP inspection by the Inspectie Gezondheidszorg en Jeug...
February 09, 2023 | News
Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across...
January 19, 2023 | News
Hitachi High-Tech Solutions Corporation, in collaboration with Keio University Faculty of Pharmacy, Department of Pharmaceutical Sciences is commenci...
January 12, 2023 | News
With ambitious plans to expand the reach and impact of their Flash Oxidation (Fox™) Protein Footprinting System beyond in vitro proteins,&n...
January 11, 2023 | News
Acquisition is expected to complement a key segment of Merck’s Semiconductor Solutions portfolio With the addition of around 100 new employees as ...
January 03, 2023 | News
LCB Grants Amgen Rights to Research, Develop, and Commercialize Antibody-Drug Conjugates Combining Targets Selected by Amgen with LCB’s Proprieta...
December 26, 2022 | News
From reagent specialist to global player with a broad network of long-standing distribution partners in more than 160 countries • Covering a compre...
December 05, 2022 | News
Most Read
Bio Jobs
News